Treatment of focal dystonias with botulinum neurotoxin

Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L. Comella

doi:10.1016/j.toxicon.2008.12.008

Treatment of focal dystonias with botulinum neurotoxin

Mark Hallett
, Reiner Benecke
, Andrew Blitzer
, Cynthia L. Comella

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Abstract

This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.

Original language	English
Pages (from-to)	628-633
Number of pages	6
Journal	Toxicon
Volume	54
Issue number	5
DOIs	https://doi.org/10.1016/j.toxicon.2008.12.008
State	Published - Oct 2009
Externally published	Yes

Keywords

Botulinum toxin
Cervical dystonia
Cranial dystonia
Focal dystonia
Focal hand dystonia
Spasmodic dysphonia

Access to Document

10.1016/j.toxicon.2008.12.008

Cite this

@article{7a35287ae31744848507200d79d99d16,

title = "Treatment of focal dystonias with botulinum neurotoxin",

abstract = "This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.",

keywords = "Botulinum toxin, Cervical dystonia, Cranial dystonia, Focal dystonia, Focal hand dystonia, Spasmodic dysphonia",

author = "Mark Hallett and Reiner Benecke and Andrew Blitzer and Comella, \{Cynthia L.\}",

note = "Funding Information: Dr. Hallett is the Chair of the Neurotoxin Institute Advisory Board, an educational organization. His funding comes from the Intramural Research Program of the National Institute of Neurological Disorders and Stroke. Dr. Benecke declares no conflicts. Dr. Blitzer has research funding from or is a consultant for Allergan, Inc., Merz, Inc., Revance, Myotech, Iridex lasers, and Xomed/Medronics. Dr. Comella is a consultant for Allergan, Boehringer Ingelheim, Cephalon., Merz, Valeant, UCB, and received research support from Allergan, Ipsen, Solstice, Merz, Boehirnger, Solvay, Parkinson Study Group, and NIH.",

year = "2009",

month = oct,

doi = "10.1016/j.toxicon.2008.12.008",

language = "English",

volume = "54",

pages = "628--633",

journal = "Toxicon",

issn = "0041-0101",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - Treatment of focal dystonias with botulinum neurotoxin

AU - Hallett, Mark

AU - Benecke, Reiner

AU - Blitzer, Andrew

AU - Comella, Cynthia L.

N1 - Funding Information: Dr. Hallett is the Chair of the Neurotoxin Institute Advisory Board, an educational organization. His funding comes from the Intramural Research Program of the National Institute of Neurological Disorders and Stroke. Dr. Benecke declares no conflicts. Dr. Blitzer has research funding from or is a consultant for Allergan, Inc., Merz, Inc., Revance, Myotech, Iridex lasers, and Xomed/Medronics. Dr. Comella is a consultant for Allergan, Boehringer Ingelheim, Cephalon., Merz, Valeant, UCB, and received research support from Allergan, Ipsen, Solstice, Merz, Boehirnger, Solvay, Parkinson Study Group, and NIH.

PY - 2009/10

Y1 - 2009/10

N2 - This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.

AB - This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.

KW - Botulinum toxin

KW - Cervical dystonia

KW - Cranial dystonia

KW - Focal dystonia

KW - Focal hand dystonia

KW - Spasmodic dysphonia

UR - https://www.scopus.com/pages/publications/68849087179

U2 - 10.1016/j.toxicon.2008.12.008

DO - 10.1016/j.toxicon.2008.12.008

M3 - Article

C2 - 19103214

AN - SCOPUS:68849087179

SN - 0041-0101

VL - 54

SP - 628

EP - 633

JO - Toxicon

JF - Toxicon

IS - 5

ER -

Treatment of focal dystonias with botulinum neurotoxin

Abstract

Keywords

Access to Document

Fingerprint

Cite this